Alimera Raises $72 Million In IPO; Clips Share Price To $11 From Initial $15-$17 Range
This article was originally published in The Pink Sheet Daily
Executive Summary
$15 million will be used to pay debt to Australian drug maker pSivida, which gave Alimera its lead compound.